Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs for Duchenne Muscular Dystrophy
NCT01610440Phase 2Unknown
- Sponsor
- Beike Biotechnology
- Start
- Oct 2011
- Primary completion
- Mar 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in Duchenne muscular dystrophy (DMD), sponsored by Beike Biotechnology. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01610440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610440.